Bilateral Thalamic Stroke: A Case of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) or a Coincidence Due to Underlying Risk Factors?

Cureus. 2021 Oct 22;13(10):e18977. doi: 10.7759/cureus.18977. eCollection 2021 Oct.


Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but potentially life-threatening side effect that has only been observed in adenovirus-based vaccines for coronavirus disease 2019 (COVID-19). VITT is an immune-mediated condition that generally presents within five to 10 days post-vaccination with thrombosis, thrombocytopenia, and coagulation abnormalities. A diagnosis of VITT is made clinically and through laboratory testing. Although VITT is an important differential to consider, it is believed that more emphasis should be placed on vaccination due to the safety and efficacy in overcoming COVID-19.

Keywords: bilateral thalamic disease; covid 19; heparin induced thrombocytopenia (hit); vaccine preventable diseases; vaccine-induced thrombotic thrombocytopenia (vitt).

Publication types

  • Case Reports